10 Nov, '2021
Acquisition strengthens Sotera Health’s quality, regulatory, and technical consulting capabilities CLEVELAND, OH – November 10, 2021 – Sotera Health, a leading global provider of mission-critical sterilization and lab-testing and advisory services announced today that it has acquired
10 Nov, '2021
Q3 2021 net revenues of $226 million increased 13%, compared to Q3 2020 Q3 2021 net income of $27 million or $0.10 per diluted share, compared to net income of $0.01 million or $0.00 per diluted share in Q3 2020 Q3 2021 Adjusted EBITDA of $117 million increased 16%, compared to Q3 2020 Q3 2021
15 Oct, '2021
CLEVELAND, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the
28 Sep, '2021
SALT LAKE CITY and OAK BROOK, Ill., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Nelson Labs and Sterigenics Germany GmbH, global leaders in comprehensive laboratory testing and sterilization services, announced today the opening of a newly expanded, center of excellence for microbiological laboratory
12 Aug, '2021
Q2 2021 net revenues of $252 million increased approximately 18%, compared to Q2 2020 Q2 2021 net income of $43 million or $0.15 per diluted share, compared to net income of $7 million or $0.03 per diluted share in Q2 2020 Q2 2021 Adjusted EBITDA of $135 million increased approximately 18%,
12 Jul, '2021
CLEVELAND, July 12, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the
13 May, '2021
Q1 2021 net revenues of $212 million increased 13%, compared to Q1 2020 Q1 2021 net income of $11 million or $0.04 per diluted share, compared to a net loss of $2 million or $0.01 per diluted share in Q1 2020; Q1 2021 includes $14 million of expense related to the repricing of the Company’s Term
27 Apr, '2021
CLEVELAND , April 27, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the
17 Mar, '2021
CLEVELAND, March 17, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock at a price to the public of $27.00 per share.
15 Mar, '2021
CLEVELAND, March 15, 2021 (GLOBE NEWSWIRE) -- Sotera Health Company (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share. All 25,000,000 shares are being offered by selling stockholders, which include